相关实验视频

Updated: Jun 17, 2025

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP
06:36

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

Published on: April 9, 2013

21.4K

一把双刃剑:不寻常的重复严重感染与pralsetinib:一个案例报告和文献综述

François Poumeaud1, Marion Jaffrelot2, Carlos Gomez-Roca3

  • 1Department of Medical Oncology, Oncopole Claudius Regaud, Toulouse, France.

Frontiers in medicine
|August 14, 2024
PubMed
概括

普拉塞提尼布有效治疗具有RET变化的癌症,但可能会增加严重感染的风险. 本病例报告详细介绍了在普拉塞替尼治疗期间发生的多种机会性感染,表明了与JAK1/2抑制的潜在联系.

关键词:
这就是JAK/STAT.这是一种RET抑制剂.案例报告案例报告感染的感染感染.这种药物是pralsetinib.

更多相关视频

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-308:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.0K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.9K

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K